P. Teirstein

P. Teirstein, G. Stone, Seung‐Jung Park, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy orEmbolization

P. Teirstein, M. Mack, J. Bavaria, 2022 .

Cost-Effectiveness of Gamma Radiation for Treatment of In-Stent Restenosis: Results From the Gamma-1 Trial

P. Teirstein, M. Leon, D. Cohen, 2002, Circulation.

Balloon occlusion and transluminal aspiration of saphenous vein grafts to prevent distal embolization

P. Teirstein, Bruce C. Stein, J. Moses, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

3 Preliminary results of gamma-I trial, multi institution double blind prospective randomized study evaluating the efficacy of IR-192 to reduce coronary in-stent restenosis

P. Teirstein, M. Leon, S. Jani, 1999 .

Invasive and Interventional Cardiology Intravascular Brachytherapy for Native Coronary Ostial In-Stent Restenotic Lesions

P. Teirstein, G. Stone, G. Dangas, 2016 .

Intracoronary radiation to treat in‐stent restenosis in six cardiac transplant patients

P. Teirstein, A. Yeung, J. Tobis, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clopidogrel desensitization after drug-eluting stent placement.

R. Valencia, P. Teirstein, M. Price, 2007, Journal of the American College of Cardiology.

Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group.

P. Teirstein, E. Topol, M. Leon, 1994, Journal of the American College of Cardiology.

Angioscopic versus angiographic detection of thrombus during coronary interventional procedures.

P. Teirstein, R. Schatz, S. Denardo, 1995, The American journal of cardiology.

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

P. Teirstein, M. Price, E. Topol, 2009, American heart journal.

Theoretical assessment of late cardiac complication from endovascular brachytherapy for restenosis prevention.

P. Teirstein, P. Tripuraneni, H. Giap, 1999, Cardiovascular radiation medicine.

Effect of Combined Anticoagulation and Low-Dose Aspirin Treatment on Upper Gastrointestinal Bleeding

P. Teirstein, R. Schatz, Z. Younossi, 2004, Digestive Diseases and Sciences.

High speed rotational coronary atherectomy for patients with diffuse coronary artery disease.

P. Teirstein, R. Ginsburg, Nowreen Haq, 1991, Journal of the American College of Cardiology.

Long-Term Safety and Efficacy of Platinum€Chromium Everolimus-Eluting Stents in Coronary Artery Disease

P. Teirstein, G. Stone, N. Hagiwara, 2017 .

Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization.

P. Teirstein, M. Price, J. Moses, 2006, Journal of the American College of Cardiology.

Percutaneous coronary intervention use in the United States: defining measures of appropriateness.

P. Teirstein, J. Moses, J. Lasala, 2012, JACC. Cardiovascular interventions.

Clinical outcomes following predilation with a novel 1.25‐mm diameter angioplasty catheter

P. Teirstein, M. Price, Subhash Banerjee, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial).

P. Teirstein, J. Moses, M. Leon, 2002, The American journal of cardiology.

Effect of Intracoronary &ggr;-Radiation Therapy on In-Stent Restenosis: An Intravascular Ultrasound Analysis from the Gamma-1 Study

P. Teirstein, N. Weissman, M. Leon, 2000, Circulation.

Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts.

P. Teirstein, S. Denardo, D. Rubenson, 1995, The American journal of cardiology.

Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996.

P. Teirstein, P. Serruys, C. Grines, 1997, Circulation.

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus.

E. Antman, P. Teirstein, F. Van de Werf, 2002, American heart journal.

One‐year results of the ICON (ionic versus non‐ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study

P. Teirstein, G. Dangas, R. Mehran, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).

P. Teirstein, B. Gersh, P. Serruys, 2008, The American journal of cardiology.

Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.

P. Teirstein, W. Laskey, S. Silber, 2003, International journal of radiation oncology, biology, physics.

Quality of life with PCI versus medical therapy in stable coronary disease.

P. Teirstein, D. Kandzari, Ryan Brown, 2008, The New England journal of medicine.

Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers.

P. Teirstein, M. Price, 2008, The American journal of cardiology.

Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.

G. Wong, P. Teirstein, M. Price, 2006, The American journal of cardiology.

A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.

P. Teirstein, M. Price, F. Burzotta, 2008, American heart journal.

Complications of Percutaneous Coronary Intervention

P. Teirstein, J. Moses, M. Eng, 2012 .

Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis

P. Teirstein, G. Stone, G. Dangas, 2004, Circulation.

Prevention of coronary restenosis.

P. Teirstein, P. Casterella, 1999, Cardiology in review.

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

R. Califf, P. Teirstein, E. Topol, 1999 .

The pineal gland does not control rod outer segment shedding and phagocytosis in the rat retina and pigment epithelium.

P. Teirstein, G. Chader, M. Tamai, 1978, Investigative ophthalmology & visual science.

Evidence for both local and central regulation of rat rod outer segment disc shedding.

A. Goldman, P. Teirstein, P. O’Brien, 1980, Investigative ophthalmology & visual science.

Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions

P. Teirstein, E. Topol, A. Lincoff, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Post-intervention cardiac enzyme elevations: Prognostic significance in IMPACT II

R. Califf, P. Teirstein, E. Topol, 1996 .

Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.

P. Teirstein, A. Kirtane, Xiantao Song, 2010, The American journal of cardiology.

Effect of the PercuSurge GuardWire Device on the Integrity of Microvasculature and Clinical Outcomes During Primary Transradial Coronary Intervention in Acute Myocardial Infarction

P. Teirstein, S. Ellis, R. Schatz, 2003 .

Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity.

P. Teirstein, M. Price, S. Murray, 2010, JACC. Cardiovascular interventions.

Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon.

P. Teirstein, G. Stone, G. Dangas, 2007, The American journal of cardiology.

P 2 Y 12 Assay : Impact on Thrombosis and Safety ( GRAVITAS ) Trial Intervention : A Time-Dependent Analysis of the Gauging Responsiveness With a Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary

P. Teirstein, M. Price, E. Topol, 2011 .

Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.

P. Teirstein, M. Price, D. Baim, 2006, The American journal of cardiology.

PTCA of the left coronary artery when the right coronary artery is chronically occluded.

P. Teirstein, B. Rutherford, D. Mcconahay, 1990, American heart journal.

Angiographic Follow-Up f Sirolimus-Eluting Stents for Unprotected eft Main Coronary Artery Revascularization

P. Teirstein, M. Leon, R. Costa, 2016 .

Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve).

P. Teirstein, M. Mack, J. Bavaria, 2013, Journal of the American College of Cardiology.

2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.

P. Teirstein, T. Bajwa, G. Deeb, 2022, Journal of the American College of Cardiology.

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.

R. Califf, P. Teirstein, E. Topol, 1999, Journal of the American College of Cardiology.

Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.

R. Califf, P. Teirstein, A. Lincoff, 2003, Journal of interventional cardiology.

A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.

Biswajit Kar, Jeffrey Moses, José P S Henriques, 2009, JACC. Cardiovascular interventions.

North American Expert Review of Rotational Atherectomy.

Samin K. Sharma, P. Teirstein, C. Grines, 2019, Circulation. Cardiovascular interventions.

Retrieval and analysis of particulate debris after saphenous vein graft intervention.

P. Teirstein, R. Virmani, F. Kolodgie, 1999, Journal of the American College of Cardiology.

Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure.

Raghava R. Gollapudi, R. Valencia, Steve S. Lee, 2006, The American journal of cardiology.

Dual catheter technique for the treatment of severe coronary artery perforations

P. Teirstein, G. Dangas, J. Moses, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Angiography versus intravascular ultrasound-directed stent placement

P. Teirstein, R. Russo, 1996 .

Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial

P. Teirstein, M. Price, C. Cannon, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Early clinical results with the new oral glycoprotein IIb/IIIa agents.

P. Teirstein, 1999, The American journal of cardiology.

Stenting for acute myocardial infarction: The early United States multicenter experience

P. Teirstein, S. Steinhubl, E. Topol, 1996 .

Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial).

Raghava R. Gollapudi, R. Valencia, Steve S. Lee, 2007, The American journal of cardiology.

Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.

P. Teirstein, A. Yeung, M. Mack, 2014, JACC. Cardiovascular interventions.

An embolization containment device

P. Teirstein, R. Virmani, D. Baim, 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Nonsurgical removal of Angio‐Seal device after intra‐arterial deposition of collagen plug

P. Teirstein, B. Stein, Bruce C. Stein, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A case of an entrapped rotational atherectomy burr

P. Teirstein, M. Grise, M. Yeager, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Complications of human coronary rotablation

P. Teirstein, R. Ginsburg, D. Warth, 1990 .

Arnon Blum Role of Lymphocytes in Heart Disease

P. Teirstein, P. Serruys, C. Grines, 1998 .

Integrelin for emergency coronary artery stenting

P. Teirstein, E. Topol, J. Muhlestein, 1996 .

A novel technique for ultra‐low contrast administration during angiography or intervention

Keshav R. Nayak, P. Teirstein, M. Price, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Differences in TIMI frame count following successful reperfusion with stenting or percutaneous transluminal coronary angioplasty for acute myocardial infarction.

P. Teirstein, D. Brown, P. Phillips, 1999, The American journal of cardiology.

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.

R. Califf, P. Teirstein, E. Topol, 1997, The American journal of cardiology.

P. Teirstein, A. Skanes, J. Moses, 2005, Journal of the American College of Cardiology.

Ballooning the aortic valve under pressure

P. Teirstein, M. Eng, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Inﬂuence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention The

N. Schork, P. Teirstein, M. Price, 2012 .

Prognostic signiﬁcance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

Raghava R. Gollapudi, R. Valencia, P. Teirstein, 2008 .

Kissing Palmaz-Schatz stents for coronary bifurcation stenoses.

P. Teirstein, 1996, Catheterization and cardiovascular diagnosis.

The dueling hazards of incomplete revascularization and incomplete data.

P. Teirstein, 2006, Circulation.

Cardiopulmonary support for complex angioplasty.

P. Teirstein, J. C. Harrington, 1995, Journal of interventional cardiology.

Intracoronary radiation therapy for multi‐drug resistant in‐stent restenosis: Initial clinical experience

P. Teirstein, M. Price, H. Giap, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis

Samin K. Sharma, P. Teirstein, W. O’Neill, 2005 .

Two-year clinical follow-up of Sr/Y h-radiation versus placebo control for the treatment of in-stent restenosis

Samin K. Sharma, P. Teirstein, S. Silber, 2005 .

Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial.

P. Teirstein, A. Yeung, G. Stone, 2003, The American journal of cardiology.

Change we can believe in: the hyper-evolution of percutaneous coronary intervention for unprotected left main disease with drug-eluting stents.

P. Teirstein, M. Price, D. Kandzari, 2008, Circulation. Cardiovascular interventions.

New Frontiers in Interventional Cardiology: Intravascular Radiation to Prevent Restenosis

P. Teirstein, R. Kuntz, 2001, Circulation.

A chicken in every pot and a drug-eluting stent in every lesion.

P. Teirstein, 2004, Circulation.

A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions.

P. Teirstein, G. Stone, P. Whitlow, 2002, Journal of the American College of Cardiology.

Frequency and nonsurgical therapy of femoral artery pseudoaneurysm complicating interventional cardiology procedures.

P. Teirstein, R. Schatz, S. Otis, 1994, The American journal of cardiology.

Clinical Outcomes Prior to and Following Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2019, Circulation.

Utility of standby cardiopulmonary support for elective coronary interventions

P. Teirstein, R. Schatz, E. Guarneri, 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption

P. Teirstein, G. Stone, S. Ellis, 2019, Circulation.

Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.

P. Teirstein, J. Moses, M. Leon, 2006, The American journal of cardiology.

Rotational atherectomy or balloon angioplasty in the treatment of intra‐stent restenosis: BARASTER Multicenter Registry

P. Teirstein, S. Goldberg, H. Dauerman, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Complications with drug-eluting stents: my worst nightmares

P. Teirstein, M. Price, 2005 .

The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry.

P. Teirstein, S. Kapadia, C. Simpfendorfer, 2001, The American journal of cardiology.

1025-41 Insulin sensitizers are associated with improved outcomes in diabetic patients undergoing brachytherapy

P. Teirstein, M. Grise, J. Kao, 2004 .

The platelet function dose‐response to abciximab during percutaneous coronary revascularization is variable

P. Teirstein, S. Steinhubl, D. Moliterno, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.

Keshav R. Nayak, P. Teirstein, M. Price, 2009, The American journal of cardiology.

Drug-eluting stent restenosis: an uncommon yet pervasive problem.

P. Teirstein, 2010, Circulation.

An Uncommon Yet Pervasive Problem

P. Teirstein, 2010 .

Living the dream of no restenosis.

P. Teirstein, 2001, Circulation.

Short-term (1 month) results of the dose response IRIS feasibility study of a beta-particle emitting radioisotope stent

P. Teirstein, N. Weissman, S. Ellis, 1998 .

Prevention of vascular restenosis with radiation.

P. Teirstein, 1998, Texas Heart Institute journal.

Coronary stenting with angioscopic guidance.

P. Teirstein, R. Schatz, S. C. Wong, 1995, The American journal of cardiology.

Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion.

P. Teirstein, C. Grines, A. Lansky, 1999, The American journal of cardiology.

Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).

P. Teirstein, M. Price, P. Serruys, 2009, The American journal of cardiology.

The off‐ versus on‐label use of medical devices in interventional cardiovascular medicine: Clarifying the ambiguity between regulatory labeling and clinical decision‐making, Part 1: PCI

P. Teirstein, M. Price, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prophylactic versus standby cardiopulmonary support for high risk percutaneous transluminal coronary angioplasty.

P. Teirstein, Sidney C. Smith, W. O’Neill, 1993, Journal of the American College of Cardiology.

Theoretical assessment of dose-rate effect in endovascular brachytherapy.

P. Teirstein, P. Tripuraneni, H. Giap, 1999, Cardiovascular radiation medicine.

A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial.

P. Teirstein, M. Leon, R. Schatz, 1998, International journal of radiation oncology, biology, physics.

Procedural effectiveness of a novel 1.20 mm diameter angioplasty catheter: clinical and angiographic outcomes.

P. Teirstein, W. Cheong, D. Kandzari, 2013, Journal of interventional cardiology.

Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.

P. Teirstein, L. Mauri, L. Satler, 2012, American heart journal.

Reduced Myocardial Flow Reserve Does Not Impair Exercise Capacity in Asymptomatic Men

P. Teirstein, R. Testa, F. Crea, 1999 .

Initial Report of Gamma Radiotherapy for Diffuse Coronary Restenosis: The SCRIPPSII Trials

P. Teirstein, M. Leon, J. Popma, 1998 .

Intravascular ultrasound identification of stent entrapment in vivo with in vitro confirmation.

P. Teirstein, J. Tobis, L. Yeatman, 1997, Catheterization and cardiovascular diagnosis.

Coronary stenting versus balloon angioplasty for unstable angina

P. Teirstein, M. Savage, D. Fischman, 1998 .

Three‐year follow‐up after intravascular γ‐radiation for in‐stent restenosis in saphenous vein grafts

P. Teirstein, K. Kent, A. Pichard, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Rescue percutaneous coronary intervention early after coronary artery bypass grafting in the drug-eluting stent era.

P. Teirstein, M. Price, Leland Housman, 2006, The American journal of cardiology.

Clinical outcomes after sirolimus‐eluting stent implantation for de novo saphenous vein graft lesions

P. Teirstein, M. Price, R. Schatz, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Teirstein and Kuntz Intravascular Radiation to Prevent Restenosis 2621

P. Teirstein, R. Kuntz, 2001 .

Intravascular Radiation to Prevent Restenosis

P. Teirstein, R. Kuntz, 2001 .

CLINICAL STUDIES Transmyocardial Revascularization A Prospective , Multicenter , Randomized Trial of Percutaneous Transmyocardial Laser Revascularization in Patients With Nonrecanalizable Chronic Total Occlusions

P. Teirstein, G. Stone, P. Whitlow, 2016 .

Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.

Andrew K. Udit, P. Teirstein, M. G. Finn, 2011, Thrombosis research.

Five-year follow up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial

Hong Wang, Giora Weisz, Jeffrey W Moses, 2009 .

Effects of Transcendental Meditation on Symptoms and Electrocardiographic Changes in Patients With Cardiac Syndrome X

P. Teirstein, M. Leon, R. Schatz, 2000 .

Credentialing for coronary interventions. Practice makes perfect.

P. Teirstein, 1997, Circulation.

Long-Term Outcome of Patients Treated With Repeat Percutaneous Coronary Intervention After Failure of &ggr;-Brachytherapy for the Treatment of In-Stent Restenosis

P. Teirstein, J. Moses, M. Leon, 2002, Circulation.

Prolonged antiplatelet therapy and reduced stenting eliminates late thrombosis after radiation: the SCRIPPS III trial

P. Teirstein, J. Moses, M. Leon, 2002 .

711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary Revascularization

R. Califf, P. Teirstein, E. Topol, 1995 .

Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators.

P. Teirstein, M. Leon, S. Ellis, 1999, Circulation.

Fate of lesion-related side branches after coronary artery stenting.

P. Teirstein, M. Leon, S. Ellis, 1993, Journal of the American College of Cardiology.

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Jeffrey W Moses, Martin B Leon, P. Teirstein, 2003, The New England journal of medicine.

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2017, Journal of the American College of Cardiology.

Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients

Andrew S. Mugglin, P. Teirstein, D. Adams, 2019, The New England journal of medicine.

Analysis of errors in measurement of cardiac output by simultaneous dye and thermal dilution in cardiothoracic surgical patients.

A. M. Benis, P. Teirstein, R. Litwak, 1978, Cardiovascular research.

Beta-radiation to reduce restenosis. Too little, too soon?

P. Teirstein, P Teirstein, 1997, Circulation.

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

N. Schork, P. Teirstein, M. Price, 2011, JAMA.

Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study.

N. Schork, P. Teirstein, M. Price, 2012, Journal of the American College of Cardiology.

Aspirin sensitivity: implications for patients with coronary artery disease.

Raghava R. Gollapudi, P. Teirstein, R. Simon, 2004, JAMA.

Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

P. Teirstein, David O. Williams, P. Block, 2009, JACC. Cardiovascular interventions.

Initial clinical application of a novel coronary angioplasty guide catheter exchange device.

P. Teirstein, 1994, Catheterization and cardiovascular diagnosis.

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

R. Califf, Á. Avezum, E. Antman, 2004, JAMA.

Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial.

R A Schatz, P. Teirstein, M. Leon, 2000, Circulation.

Catheter-based radiotherapy to inhibit restenosis after coronary stenting.

R A Schatz, P. Teirstein, M. Leon, 1997, The New England journal of medicine.

74 – Interventional and Surgical Treatment of Coronary Artery Disease

P. Teirstein, B. Lytle, 2012 .

Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study

Julio C. Palmaz, Eric J. Topol, Sheldon Goldberg, 1991, Circulation.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

P. Teirstein, G. Stone, S. Ellis, 2015, The New England journal of medicine.

Risk Assessment in Patient Selection for Transcatheter Aortic Valve Replacement.

P. Teirstein, M. Price, C. Stinis, 2015, Interventional cardiology clinics.

Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.

Antonio Colombo, Takahiko Suzuki, Patrick W Serruys, 2005, Circulation.

Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II

Gary S. Mintz, Antonio Colombo, Jeffrey W. Moses, 2005, Circulation.

Paclitaxel prevented restenosis in a totally occluded small vessel with in‐stent restenosis: A 9‐month angiographic follow‐up

P. Teirstein, G. Roubin, Ali F. Aboufares, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The role of ambient lighting in circadian disc shedding in the rod outer segment of the rat retina.

A. Goldman, P. Teirstein, P. O’Brien, 1980, Investigative ophthalmology & visual science.

Sirolimus-eluting stent for the treatment of bypass graft disease: The initial U.S. Experience

P. Teirstein, J. Moses, M. Leon, 2003 .

A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial.

V. Hasselblad, P. Teirstein, K. Mahaffey, 2001, Journal of the American College of Cardiology.

Is surgery or percutaneous revascularization the preferred strategy for patients with significant left main coronary stenosis

P. Teirstein, 2009 .

Restenosis after angioplasty

P. Teirstein, P. Casterella, Mehran Moussavian, 2001, Current treatment options in cardiovascular medicine.

Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).

P. Teirstein, G. Stone, G. Dangas, 2005, The American journal of cardiology.

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.

P. Teirstein, J. Moses, M. Leon, 2001, The New England journal of medicine.

The American Brachytherapy Society perspective on intravascular brachytherapy.

P. Teirstein, S. Nag, R. Nath, 1999, Cardiovascular radiation medicine.

Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation☆

P. Teirstein, E. Topol, M. Leon, 1994 .

Effect of intracoronary stenting on intimal dissection after balloon angioplasty: results of quantitative and qualitative coronary analysis.

P. Teirstein, M. Leon, S. Ellis, 1991, Journal of the American College of Cardiology.

Barotrauma due to stent deployment in endovascular brachytherapy for restenosis prevention.

P. Teirstein, P. Tripuraneni, H. Giap, 2000, International journal of radiation oncology, biology, physics.

Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group.

P. Teirstein, M. Leon, S. Ellis, 1995, Journal of the American College of Cardiology.

Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts.

P. Teirstein, R. Schatz, S. C. Wong, 1995, The American journal of cardiology.

The clinical utility of angioscopy during intracoronary stent implantation.

P. Teirstein, R. Schatz, M. J. Senneff, 1994, Journal of interventional cardiology.

Coronary angioscopy before and after stent deployment

Richard R. Heuser, Robert K. Strumpf, Scott J. Denardo, 1993, Photonics West - Lasers and Applications in Science and Engineering.

902-7 Ultrasound Guided Coronary Stent Placement without Prolonged Systemic Anticoagulation

P. Teirstein, J. Tobis, R. Schatz, 1995 .

Long-Term Outcome of Patients Treated With Repeat Percutaneous Coronary Intervention After Failure of -Brachytherapy for the Treatment of In-Stent Restenosis

P. Teirstein, J. Moses, M. Leon, 2002 .

Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.

P. Teirstein, A. Yeung, P. Fitzgerald, 2000, Circulation.

Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.

P. Teirstein, G. Stone, N. Hagiwara, 2017, JACC. Cardiovascular interventions.

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.

Gregg W Stone, P. Teirstein, G. Stone, 2011, Journal of the American College of Cardiology.

Sr/Y -Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

Randomized Trial of 90 Sr / 90 Y-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

The truth and consequences of the COURAGE trial.

P. Teirstein, G. Stone, W. O’Neill, 2007, Journal of the American College of Cardiology.

Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.

P. Teirstein, G. Stone, J. Moses, 2020, Journal of the American College of Cardiology.

Randomized Trial of 90Sr/90Y β-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

Richard R. Heuser, Theodore A. Bass, Jeffrey J. Popma, 2002 .

Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results

Antonio Colombo, Takahiko Suzuki, Patrick W Serruys, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents

G. Breithardt, P. Teirstein, A. J. O’Malley, 2005, Circulation.

Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial.A Stent vs. Stent Ultrasound Remodeling Evaluation.

P. Teirstein, P. Fitzgerald, P. Yock, 2001, Journal of the American College of Cardiology.

Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.

A James O'Malley, Laura Mauri, Jeffrey W Moses, 2005, The American journal of cardiology.

Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts.

P. Teirstein, K. Kent, A. Pichard, 2002, The New England journal of medicine.

Coronary Artery Disease: Radiation Therapy

P. Teirstein, 2000 .

Repeat coronary angioplasty: efficacy of a third angioplasty for a second restenosis.

P. Teirstein, B. Rutherford, D. Mcconahay, 1989, Journal of the American College of Cardiology.

Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial.

P. Teirstein, M. Leon, R. Schatz, 1999, The American journal of cardiology.

Percutaneous Recanalization of Chronically Occluded Coronary Arteries A New Drugs and Technologies

P. Teirstein, P. Serruys, G. Dangas, 2005 .

Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study

P. Teirstein, A. Yeung, P. Fitzgerald, 2000 .

Five-Year Clinical Follow-Up After Intracoronary Radiation: Results of a Randomized Clinical Trial

P. Teirstein, M. Leon, R. Schatz, 2002, Circulation.

The role of maintenance of certification programs in governance and professionalism.

P. Teirstein, E. Topol, 2015, JAMA.

3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.

P. Teirstein, L. Mauri, L. Satler, 2008, JACC. Cardiovascular interventions.

Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.

P. Teirstein, P. Fitzgerald, L. Satler, 2006, JAMA.

Pilot Trial of Oral Rapamycin for Recalcitrant Restenosis

P. Teirstein, R. Schatz, M. Grise, 2003, Circulation.

Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation

P. Teirstein, M. Price, T. Ahern, 2012, Journal of cardiovascular medicine.

Boarded to death--why maintenance of certification is bad for doctors and patients.

P. Teirstein, Paul S Teirstein, 2015, The New England journal of medicine.

Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula.

P. Teirstein, P. Yock, R. Popp, 1986, Journal of the American College of Cardiology.

A quantitative system for studying phagocytosis in pigment epithelium tissue culture.

P. Teirstein, G. Chader, P. O’Brien, 1979, Experimental eye research.

Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.

P. Teirstein, A. Kirtane, G. Dangas, 2009, JACC. Cardiovascular interventions.

Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.

P. Teirstein, G. Stone, Seung‐Jung Park, 2009, Journal of the American College of Cardiology.

Intracoronary stenting to prevent restenosis: Preliminary results of a multicenter study using the palmaz-schatz stent suggest benefit in selected high risk patients

P. Teirstein, E. Topol, S. Ellis, 1990 .

Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis

P. Teirstein, 2009, Circulation.

Unprotected left main intervention: patient selection, operator technique, and clinical outcomes.

P. Teirstein, 2008, JACC. Cardiovascular interventions.

Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry

P. Teirstein, M. Price, J. Moses, 2009, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Nonoperative management of aortocoronary saphenous vein graft rupture during percutaneous transluminal coronary angioplasty.

P. Teirstein, G. Hartzler, 1987, The American journal of cardiology.

High-speed rotational atherectomy of tortuous coronary arteries with guidewire-associated pseudostenosis.

P. Teirstein, R. Schatz, E. Guarneri, 1996, Catheterization and cardiovascular diagnosis.

Centered versus noncentered source for intracoronary artery radiation therapy: a model based on the Scripps Trial.

P. Teirstein, C. Levin, V. Bhargava, 2002, American heart journal.

Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stents.

P. Teirstein, G. Stone, N. Hagiwara, 2014, Journal of cardiology.

apanese and non-Japanese patient outcomes in the PLATINUM andomized trial comparing the PROMUS Element and XIENCE V verolimus-eluting stents

P. Teirstein, G. Stone, N. Hagiwara, 2014 .

A Randomized Controlled Trial of Angiography Versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial)

P. Teirstein, S. Goldberg, P. Fitzgerald, 2009, Circulation. Cardiovascular interventions.

Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque

P. Teirstein, G. Stone, J. Moses, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents

P. Teirstein, J. Moses, M. Leon, 2004, Circulation.

Hugging balloons: coronary angioplasty of oversized vessels with side-by-side balloons.

P. Teirstein, B. Rutherford, W. Johnson, 1988, Catheterization and cardiovascular diagnosis.

Left main percutaneous coronary intervention.

P. Teirstein, M. Price, 2012, Journal of the American College of Cardiology.

Fluorescence-guided laser-assisted balloon angioplasty in patients with femoropopliteal occlusions.

P. Teirstein, D. Miller, M. Leon, 1990, Circulation.

Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study).

P. Teirstein, G. Stone, T. Henry, 2005, The American journal of cardiology.

Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons.

P. Teirstein, M. Mack, J. Bavaria, 2014, Journal of the American College of Cardiology.

The accuracy of Doppler ultrasound measurement of pressure gradients across irregular, dual, and tunnellike obstructions to blood flow.

P. Teirstein, P. Yock, R. Popp, 1985, Circulation.

PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.

P. Teirstein, R. Whitbourn, G. Stone, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Source displacement during the cardiac cycle in coronary endovascular brachytherapy.

P. Teirstein, P. Tripuraneni, H. Giap, 2001, International journal of radiation oncology, biology, physics.

Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials.

P. Teirstein, G. Stone, D. Kandzari, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Brachytherapy for in‐stent restenosis through the internal mammary artery

P. Teirstein, J. Moses, M. Leon, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The "Concorde" stent: a novel use of a stiff bent guidewire to facilitate stent deployment.

P. Teirstein, T. A. Carlson, 1997, Catheterization and Cardiovascular Diagnosis.

Guidewire techniques and technologies: hydrophilic versus stiff wire selection

G. Wong, P. Teirstein, M. Price, 2007 .

THREE–YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE v EVEROLIMUS–ELUTING STENTS

P. Teirstein, G. Stone, S. Saito, 2013 .

Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).

P. Teirstein, R. Wilensky, J. Moses, 2007, The American journal of cardiology.

New Frontiers in Interventional Cardiology

P. Teirstein, R. Kuntz, 2001 .

Randomized Trial of 90Sr/90Y &bgr;-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002, Circulation.

The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).

P. Teirstein, J. Moses, M. Leon, 2006, The American journal of cardiology.

Technique for shortening angioplasty guide catheter length when therapeutic catheter fails to reach target stenosis.

P. Teirstein, R. Ginsberg, R. Schatz, 1993, Catheterization and cardiovascular diagnosis.

Clinical Trial Five-Year Clinical Follow-Up After Intracoronary Radiation : Results of a Randomized

P. Teirstein, M. Leon, J. Popma, 2002 .

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

P. Teirstein, J. Moses, M. Leon, 1994, The New England journal of medicine.

Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty.

P. Teirstein, E. Topol, F. Shawl, 1990, Journal of the American College of Cardiology.

Long-Term Outcome of Patients Treated With Repeat Percutaneous Coronary Intervention After Failure of-Brachytherapy for the Treatment of In-Stent Restenosis

P. Teirstein, J. Moses, M. Leon, 2002 .

Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III).

P. Teirstein, G. Stone, G. Dangas, 2003, The American journal of cardiology.

Fulfilling the promise of percutaneous angioplasty.

P. Teirstein, 2000, Circulation.

Vascular radiation in a drug-eluting stent world: it's not over till it's over.

P. Teirstein, S. King, 2003, Circulation.

How long is enough? Defining the treatment length in endovascular brachytherapy

Wim Dries, Shirish Jani, Paul Teirstein, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

FINAL FIVE-YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE V EVEROLIMUS-ELUTING STENTS IN WORKHORSE LESIONS

P. Teirstein, G. Stone, N. Hagiwara, 2015 .

Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial).

P. Teirstein, G. Stone, I. Meredith, 2014, American Journal of Cardiology.

Clinical ResearchInterventional CardiologyFive-Year Follow-Up After Sirolimus-Eluting Stent Implantation: Results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial

P. Teirstein, Hong Wang, J. Moses, 2009 .

Early lumen loss after repeat coronary intervention for in‐stent restenosis

P. Teirstein, R. Schatz, S. Jani, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.

P. Teirstein, J. Moses, M. Leon, 2005, The Journal of invasive cardiology.

Teirstein Fulfilling Promise of Percutaneous Angioplasty 2675

P. Teirstein, 2000 .

Endovascular brachytherapy to inhibit coronary artery restenosis: an introduction to the SCRIPPS Coronary Radiation to Inhibit Proliferation Post Stenting trial.

P. Teirstein, M. Leon, R. Schatz, 1996, International journal of radiation oncology, biology, physics.

Gamma versus Beta Radiation for the Treatment of Restenosis

P. Teirstein, 1998, Herz.

A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

P. Teirstein, D. Fischman, D. Baim, 1994 .

P. Teirstein, M. Price, P. Serruys, 2009, The American journal of cardiology.

Element) for the Treatment of up to Two De Novo Coronary Artery Lesions) Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Coronary Stent: The PLATINUM (A Prospective, Randomized, Multicenter A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting

P. Teirstein, G. Stone, N. Hagiwara, 2011 .

Percutaneous coronary intervention use in the United States: defining measures of appropriateness.

P. Teirstein, J. Moses, J. Lasala, 2012, JACC. Cardiovascular interventions.

Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention

P. Teirstein, S. Steinhubl, G. Dangas, 2001 .

Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis

P. Teirstein, 2009, Circulation.

Unprotected left main intervention: patient selection, operator technique, and clinical outcomes.

P. Teirstein, 2008, JACC. Cardiovascular interventions.

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

N. Schork, P. Teirstein, M. Price, 2011, JAMA.

Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial).

P. Teirstein, G. Stone, I. Meredith, 2014, The American journal of cardiology.

P. Teirstein, David O. Williams, P. Block, 2009, JACC. Cardiovascular interventions.

CORONARY ARTERY DISEASE Original Studies Utility of Three-Dimensional Reconstruction of Coronary Angiography to Guide Percutaneous Coronary Intervention

Raghava R. Gollapudi, R. Valencia, P. Teirstein, 2007 .

Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

P. Teirstein, D. Kandzari, D. Angiolillo, 2011 .

Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.

P. Teirstein, J. Bavaria, C. Hengstenberg, 2019, Circulation.

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.

Sara K. Rostanski, P. Teirstein, J. Bavaria, 2022, JAMA cardiology.

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

P. Teirstein, G. Stone, S. Ellis, 2017, Journal of the American College of Cardiology.

5-YEAR FINAL RESULTS OF THE SISR (SIROLIMUS-ELUTING STENTS VERSUS VASCULAR BRACHYTHERAPY FOR IN-STENT RESTENOSIS) TRIAL

P. Teirstein, L. Mauri, L. Satler, 2011 .

A novel technique for ultra‐low contrast administration during angiography or intervention

Keshav R. Nayak, P. Teirstein, M. Price, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Change we can believe in: the hyper-evolution of percutaneous coronary intervention for unprotected left main disease with drug-eluting stents.

P. Teirstein, M. Price, D. Kandzari, 2008, Circulation. Cardiovascular interventions.

Drug-eluting stent restenosis: an uncommon yet pervasive problem.

P. Teirstein, 2010, Circulation.

4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial.

P. Teirstein, H. Gada, B. Ramlawi, 2023, Journal of the American College of Cardiology.

Three-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis.

P. Teirstein, K. Goel, T. Bajwa, 2023, Journal of the American College of Cardiology.

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

P. Teirstein, M. Price, E. Topol, 2009, American heart journal.